Narrative review / 2012
Evidence linking calcium supplement use to increased cardiovascular disease risk is insufficient to alter dietary recommendations, according to an expert review.
A panel of academic and industry experts reviewed epidemiological studies and randomized controlled trial meta-analyses evaluating calcium supplement use and cardiovascular disease risk using four Bradford Hill criteria. Although some studies reported a potential association with a small increase in adverse cardiovascular events, the authors identified limitations such as inadequate compliance, use of nontrial calcium, event ascertainment bias, and unadjusted confounders. Furthermore, other cohort studies showed no detrimental effect on cardiovascular risk from dietary or supplemental calcium, and plausible biological mechanisms remain lacking. The authors concluded current evidence does not warrant changes to Institute of Medicine calcium intake recommendations.
- Study type
- Expert narrative review
- Who was studied
- Individuals examined across epidemiological and clinical trial datasets
- What was measured
- Cardiovascular events and cardiovascular disease risk
THE PAPER
A review of calcium supplements and cardiovascular disease risk.
Heaney RP, Kopecky S, Maki KC, Hathcock J, Mackay D, Wallace TC. Adv Nutr, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.